Oneness Biotech Co., Ltd.

Oneness Biotech Co., Ltd. receives the United States patent on the producing recombinant glycoproteins with modified glycosylation.

2023-06-01

Statement
No	1	Date of announcement	2023/06/01	Time of announcement	17:35:53
Subject	Oneness Biotech Co., Ltd. receives the United States patent on the producing recombinant glycoproteins with modified glycosylation.
To which item it meets	paragraph 53			Date of events	2023/06/01
Date of occurrence of the event:2023/06/01 Company name:ONENESS BIOTECH CO., LTD. Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office Reciprocal shareholding ratios:NA Cause of occurrence:The Company has been informed by the patent agency that the methods for glycan modification on recombinant protein, has been granted the United States patent entitled ”METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION”under the patent number US 11,439,682 B2. Countermeasures:None Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):None

NEWS